Drugdevcompare
Welcome GuestUnited States
Login Register
  • Home
  • Product and Service Directory
  • Featured Products/Services
  • Articles
  • White Papers
  • Application Notes
  • News
  • Home
  • Product and Service Directory
  • BRI Biopharmaceutical Research Inc.

BRI Biopharmaceutical Research Inc. Contact Information

BRI Biopharmaceutical Research Inc.
101 - 8898 Heather Street
Vancouver, BC V6P 3S8
Canada
Phone: 604-432-9237
Web Site: www.bripharm.com

Related Service Categories

  • Active Pharmaceutical Ingredient (API) Development Services
  • Pharmaceutical Preformulation Co-Crystal Selection Services (Crystal Engineering Services)
  • Pharmaceutical Preformulation Polymorph Screening Services
  • Pharmaceutical Solubility Testing Services
  • Pharmaceutical Stability Testing Services
  • Semi-Solid Dosage Drug Formulation Development Services
  • Solid Dosage Drug Formulation Development Services
  • Topical Dosage Drug Formulation Services

White Papers / Application Notes

  • A Review of Reported Recalls Involving Microbiological Control

    Friday, March 09, 2012
  • Accelerating Generic Approvals

    Tuesday, January 17, 2012
  • AccuPRO-ID® - Bacterial Identification Using MALDI-TOF Technology

    Friday, April 20, 2012
  • Analysis of Drug Degradants by LC/MS

    Thursday, December 22, 2011

News

  • AB SCIEX Launches the World’s Most Sensitive Mass Spectrometer

    Tuesday, May 22, 2012
  • Fast Plasma Sample Cleanup with New Phree™ Phospholipid Removal Plates from Phenomenex

    Tuesday, May 22, 2012
  • Thermo Fisher Scientific Introduces Next-Generation Benchtop LC-MS System at ASMS 2012

    Tuesday, May 22, 2012
  • MPI Research Invests in an Additional Gyrolab™ xP Workstation

    Tuesday, May 22, 2012

Sections

  • Home
  • Drug Development Directory
  • Articles

Company

  • About Drugdevcompare
  • Contact Us
  • Privacy Policy
  • Disclaimer and Terms of Use

Clients

  • Advertise With Us
  • Media Kit

A Site by CompareNetworks

Copyright © 2012 CompareNetworks, Inc. All rights reserved.